Table II.

Summary ORs and 95% CI of CCND1 G870A polymorphism and esophageal cancer risk.

	A vs. G				AA vs. GG				GA vs. GG				AA + GA vs. GG				AA vs. GG + GA
P-valuea	OR	95% CI	P-value	P-valuea	OR	95% CI	P-value	P-valuea	OR	95% CI	P-value	P-valuea	OR	95% CI	P-value	P-valuea	OR	95% CI	P-value	P-valuea
Total	1.23	1.02–1.48	0.029	<0.001b	1.58	1.06–2.35	0.024	<0.001b	1.18	0.90–1.53	0.254	<0.001b	1.30	0.96–1.76	0.092	<0.001b	1.33	1.03–1.73	0.030	<0.001b
Ethnicity
Asian	1.29	0.93–1.80	0.128	0.001b	1.85	0.84–4.09	0.129	<0.001b	1.66	0.76–3.64	0.202	<0.001b	1.74	0.79–3.81	0.169	<0.001b	1.18	0.94–1.47	0.149	0.228
Caucasian	1.20	0.95–1.53	0.135	<0.001b	1.45	0.89–2.35	0.134	<0.001b	0.96	0.81–1.14	0.624	0.482	1.08	0.83–1.40	0.583	0.037b	1.44	0.97–2.14	0.070	<0.001b
Design
Hospital-based	1.24	0.93–1.66	0.144	0.026b	1.62	0.84–3.10	0.150	0.013b	1.12	0.86–1.46	0.395	0.602	1.19	0.89–1.61	0.243	0.286	1.51	0.87–2.61	0.143	0.008b
Population-based	1.39	0.94–2.04	0.096	<0.001b	2.13	0.86–5.24	0.100	<0.001b	1.68	0.74–3.81	0.216	<0.001b	1.83	0.80–4.17	0.150	<0.001b	1.39	0.90–2.15	0.135	0.035b
Pathology
ESCC	1.23	0.96–1.59	0.108	<0.001b	1.58	0.92–2.70	0.095	<0.001b	1.25	0.82–1.91	0.307	<0.001b	1.36	0.87–2.13	0.175	<0.001b	1.28	0.93–1.75	0.127	0.001
EA	1.25	0.82–1.91	0.310	0.014b	1.67	0.64–4.34	0.291	0.007b	1.11	0.83–1.49	0.469	0.396	1.18	0.77–1.81	0.443	0.167	1.59	0.69–3.70	0.280	0.004b